ANIK
Anika Therapeutics Inc.

639
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Oct 30,
Pre-Market

Estimated EPS

-$0.21

Estimated Rev

$27.53M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.21
--
--
N/A
Q2 '25
-$0.26
-$0.13
50.63%
BEAT
Q1 '25
-$0.09
-$0.06
33.33%
BEAT
Q4 '24
-$0.22
-$0.03
86.67%
BEAT
Q3 '24
$0.09
-$0.25
-377.78%
MISSED

Latest ANIK News

View

Advertisement. Remove ads.

Advertisement. Remove ads.